Statistics for BioNTech SE (id:7128 BNTX)
Valuation metrics
Market cap
28.86B
Enterprise value
12.14B
Trailing P/E (ttm)
160.80
Forward P/E
-30.87
PEG ratio
-30.87
Price/Sales (ttm)
9.49
Price/Book (mrq)
1.51
Enterprise Value/Revenue
4.08
Enterprise Value/EBITDA
-45.15
Overview
Shares outstanding
239.74M
Float
91.56M
Shares short
2.36M
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
639.00K
Average volume (90 days)
Price summary
52-Week low
76.53
52-Week high
131.49
52-Week change
5.76%
Beta
3.00
50-Day moving average
113.90
200-Day moving average
97.72
Dividends and splits
Forward annual dividend rate
8.44
Forward annual dividend yield
5.00
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
June 17, 2022
Ex-dividend date
June 2, 2022
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-15.36%
Operating margin
1.68%
Operational effectiveness
Return on assets
-1.24%
Return on equity
-2.40%
Income statement
Revenue (ttm)
12.62
Revenue per share (ttm)
12.62
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
3.22B
EBITDA
1.16B
Net income to common (ttm)
930.30M
Diluted EPS (ttm)
-2.03
Quarterly earnings growth (yoy)
23.40%
Balance sheet
Total cash (mrq)
17.57B
Total cash per share (mrq)
69.70
Total debt (mrq)
243.70M
Total Debt/Equity (mrq)
1.28
Current ratio (mrq)
732.90%
Book value per share (mrq)
79.73
Cash flow
Cash flow statement
5.72B
Levered free cash flow (LFCF)
930.30M